13.83
price down icon3.49%   -0.50
pre-market  Vorhandelsmarkt:  13.50   -0.33   -2.39%
loading
Schlusskurs vom Vortag:
$14.33
Offen:
$13.585
24-Stunden-Volumen:
11,288
Relative Volume:
0.00
Marktkapitalisierung:
$2.37M
Einnahmen:
$8.97M
Nettoeinkommen (Verlust:
$-15.21M
KGV:
-0.1187
EPS:
-116.51
Netto-Cashflow:
$-10.84M
1W Leistung:
-13.29%
1M Leistung:
+4,575%
6M Leistung:
+955.73%
1J Leistung:
+233.25%
1-Tages-Spanne:
Value
$13.50
$13.88
1-Wochen-Bereich:
Value
$13.21
$16.50
52-Wochen-Spanne:
Value
$0.19
$25.95

Nuwellis Inc Stock (NUWE) Company Profile

Name
Firmenname
Nuwellis Inc
Name
Telefon
952-345-4200
Name
Adresse
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Name
Mitarbeiter
38
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-11
Name
Neueste SEC-Einreichungen
Name
NUWE's Discussions on Twitter

Vergleichen Sie NUWE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
NUWE
Nuwellis Inc
13.83 2.37M 8.97M -15.21M -10.84M -116.51
Medical Devices icon
ABT
Abbott Laboratories
125.83 218.75B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
107.76 152.62B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
400.93 151.01B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.01 117.43B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.91 44.76B 5.54B 4.18B 623.10M 7.00

Nuwellis Inc Stock (NUWE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-29 Eingeleitet ROTH MKM Buy

Nuwellis Inc Aktie (NUWE) Neueste Nachrichten

pulisher
Jul 23, 2025

What analysts say about Nuwellis Inc. stockRecord-breaking gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Nuwellis Regains Nasdaq Compliance After Delisting Risk - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Nuwellis Regains Compliance to Trade on Nasdaq - MarketScreener

Jul 23, 2025
pulisher
Jul 23, 2025

Nuwellis regains Nasdaq compliance as minimum bid price requirement met - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Nuwellis Participates in the Virtual Investor 'What’s Your Story” Summer Spotlight On-Demand Conference - The Manila Times

Jul 23, 2025
pulisher
Jul 23, 2025

Exclusive: Nuwellis CEO Reveals Personal Journey and Strategic Roadmap in Candid Investor Interview - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

Nuwellis Regains Compliance with Nasdaq Listing Requirements - The Manila Times

Jul 23, 2025
pulisher
Jul 23, 2025

Nuwellis regains Nasdaq compliance, avoids delisting hearing - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

Nuwellis regains compliance with Nasdaq listing requirements - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Nuwellis, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement - Quiver Quantitative

Jul 23, 2025
pulisher
Jul 23, 2025

Nuwellis Secures Future on Nasdaq as Stock Meets Critical Trading Requirements - Stock Titan

Jul 23, 2025
pulisher
Jul 22, 2025

Nuwellis Inc. Stock Analysis and ForecastFree Stock Chart Pattern Guide - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Nuwellis Inc. a good long term investmentFree AI-Backed Trading Signals - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025 - The Manila Times

Jul 22, 2025
pulisher
Jul 22, 2025

Nuwellis, Medical Fluid Management Leader, Sets Q2 2025 Earnings Call for August 12 - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Why Nuwellis Inc. stock attracts strong analyst attentionFree Consultation - Newser

Jul 22, 2025
pulisher
Jul 20, 2025

What drives Nuwellis Inc. stock priceRapid-fire capital growth - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

Nuwellis Stock Rises After Hours Following Patent Win For Blood Filtering System — Retail Mood Turns Buoyant - MSN

Jul 19, 2025
pulisher
Jul 19, 2025

Nuwellis Terminates REVERSE-HF Trial, Shifts Focus to Outpatient Heart Failure Care and Pediatric Markets - AInvest

Jul 19, 2025
pulisher
Jul 19, 2025

Nuwellis Ends REVERSE-HF Trial to Focus on Growth Areas, Saves $4 Million - AInvest

Jul 19, 2025
pulisher
Jul 18, 2025

Nuwellis ends clinical trial of its ultrafiltration tech for heart failure - MassDevice

Jul 18, 2025
pulisher
Jul 18, 2025

Medical Stocks To Add to Your Watchlist – July 16th - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

Nuwellis stock falls after company terminates REVERSE-HF clinical trial By Investing.com - Investing.com South Africa

Jul 17, 2025
pulisher
Jul 17, 2025

Nuwellis stock falls after company terminates REVERSE-HF clinical trial - Investing.com

Jul 17, 2025
pulisher
Jul 17, 2025

Nuwellis' New U.S. Patent and Market Implications: A Game-Changer in Fluid Management and a Long-Term Growth Catalyst for Investors - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Nuwellis terminates REVERSE-HF trial to focus on outpatient heart failure care - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care - The Manila Times

Jul 17, 2025
pulisher
Jul 17, 2025

Nuwellis, Inc. Terminates REVERSE-HF Clinical Trial to Focus on Outpatient Market Opportunities - Nasdaq

Jul 17, 2025
pulisher
Jul 17, 2025

Nuwellis Pivots from REVERSE-HF Trial: Strategic $4M Shift to Outpatient Heart Failure Care Revealed - Stock Titan

Jul 17, 2025
pulisher
Jul 17, 2025

Nuwellis Plunges 11.29% After Patent Surge - AInvest

Jul 17, 2025
pulisher
Jul 16, 2025

Biotech And Crypto Moves Set Off Trading Frenzy - Finimize

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis Surges to 137th in Market Rankings with $703 Million Trading Volume - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis appoints John Erb as CEO - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis Secures Patent Leadership in CRRT: A Breakthrough in Fluid Management for Critical Care - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Medical Stocks To Add to Your WatchlistJuly 16th - MarketBeat

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis' Patent Breakthrough: Can Fluid Management Innovation Sustain Momentum? - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis (NUWE) Stock Skyrockets On New Patent: What's Going On? - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

Markets Inch Up As Lower Oil Prices And Flat Inflation Stand Out - Finimize

Jul 16, 2025
pulisher
Jul 16, 2025

Why Nuwellis Shares Are Exploding Today: A 200% Surge Explained - Investing.com

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis shares surge 26.71% intraday after receiving a new U.S. patent on fluid management. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Why are NUWE Shares Surging in Premarket Trading Today? - Tokenist

Jul 16, 2025
pulisher
Jul 16, 2025

NUWE Stock Soars: Will It Last? - timothysykes.com

Jul 16, 2025
pulisher
Jul 16, 2025

Why Is Nuwellis Stock (NUWE) Up 140% Today? - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis Shares Skyrocket 127.7% on Patent Win, Earnings - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis shares jump 10.16% premarket after securing new U.S. patent on fluid management. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis' Fluid Management Patent: A Strategic Leap Forward, But Can It Stem the Tide? - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis Soars 63.16% on New Patent, Earnings - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Nuwellis Stock Rises After Hours Following Patent Win For Blood Filtering SystemRetail Mood Turns Buoyant - MenaFN

Jul 16, 2025

Finanzdaten der Nuwellis Inc-Aktie (NUWE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$286.67
price up icon 0.39%
medical_devices STE
$225.47
price up icon 0.80%
medical_devices PHG
$25.85
price up icon 3.32%
$86.43
price up icon 1.54%
$77.25
price up icon 0.99%
medical_devices EW
$76.91
price up icon 0.80%
Kapitalisierung:     |  Volumen (24h):